LIFEVEST WCD 4000 SYSTEM
Report
- Report Number
- 3002158293-2011-00088
- Event Type
- Death
- Date Received
- January 26, 2011
- Date of Event
- January 9, 2011
- Report Date
- January 25, 2011
- Manufacturer
- ZOLL LIFECOR CORPORATION
- Product Code
- MVK
- PMA / PMN Number
- P010030
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- NOT APPLICABLE
Narratives
DEVICE EVAL SUMMARY: DEVICE EVALUATIONS OF MONITOR SN (B)(4) AND ELECTRODE BELT SN (B)(4) HAVE BEEN COMPLETED. THE REPORTED PROBLEM (PT DEATH/TREATMENT) WAS INVESTIGATED. UPON EVAL, BOTH THE MONITOR AND ELECTRODE BELT WERE FULLY FUNCTIONAL. THE PT WAS APPROPRIATELY TREATED, BUT THE RHYTHM WAS NOT SUCCESSFULLY CONVERTED TO A LIFE-SUSTAINING RHYTHM DUE TO IMPROPER LIFEVEST-BODY CONTACT. THE IMPROPER PLACEMENT ALSO CAUSED TWO OF THE APPROPRIATE SHOCKS TO DELIVER LOW-ENERGY PULSES (8 JOULES). THE PT ALSO RECEIVED TWO INAPPROPRIATE TREATMENTS. THE PT WAS INAPPROPRIATELY TREATED BECAUSE THE PT DID NOT USE THE RESPONSE BUTTONS PROPERLY DURING ARRHYTHMIA DETECTION CAUSED BY A COMBINATION OF SIGNAL ARTIFACT, NON-SUSTAINED VT, AND DOUBLE COUNTING. THE ROOT CAUSE FOR THE SIGNAL ARTIFACT WAS LIKELY POOR ELECTRODE PLACEMENT IN THE GARMENT. FIFTEEN MINUTES AFTER THE LAST VISIBLE ECG (SHOWING A LIFE-SUSTAINING RHYTHM), THE PT'S RHYTHM TRANSITIONED TO ASYSTOLE, A NON-TREATABLE RHYTHM. THE PT DEATH WAS REPORTEDLY DUE TO A SEIZURE.
A (B)(6) FEMALE PT'S FRIEND CONTACTED ZOLL LIFECOR CUSTOMER SUPPORT SERVICE TO REPORT THAT THE PT DIED ON (B)(6) 2011 WHILE WEARING THE LIFEVEST. SHE REPORTED THAT THE LIFEVEST ALARMED AND THE PT PRESSED THE RESPONSE BUTTONS. THE PT LATER RECEIVED A TREATMENT. A MESSAGE ON THE MONITOR THEN STATED TO CALL 911. THE PARAMEDICS ARRIVED AND PRONOUNCED THE PT DEAD DUE TO SEIZURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | LIFEVEST WCD 4000 SYSTEM | WEARABLE CARDIOVERTER DEFIBRILLATOR | MVK | ZOLL LIFECOR CORPORATION | WCD 4000 | NA |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 30 YR |